Cargando…
Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore
Autores principales: | Yew, Yik Weng, Yeo, Pei Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413341/ https://www.ncbi.nlm.nih.gov/pubmed/37575516 http://dx.doi.org/10.1016/j.jdin.2023.06.005 |
Ejemplares similares
-
Recalcitrant prurigo nodularis treated successfully with dupilumab
por: Rambhia, Pooja H., et al.
Publicado: (2019) -
Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis
por: Fölster-Holst, Regina, et al.
Publicado: (2021) -
Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
por: Bloomstein, Joshua D., et al.
Publicado: (2021) -
Dupilumab for the treatment of prurigo nodularis: A systematic review
por: Cao, Peng, et al.
Publicado: (2023) -
A Case of Linear Exacerbation of Atopic Dermatitis with Secondary Prurigo Nodularis
por: Kang, Hyun Jin, et al.
Publicado: (2022)